|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Artiva Biotherapeutics, Inc. (ARTV) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
24,295,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
13,749,996 |
13,749,996 |
| Total Buy Value |
$0 |
$0 |
$164,999,952 |
$164,999,952 |
| Total People Bought |
0 |
0 |
5 |
5 |
| Total Buy Transactions |
0 |
0 |
6 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Banerjee Subhashis |
Chief Medical Officer |
• – – |
2025-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Aslan Fred |
President and CEO |
• • – |
2025-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
416,665 |
|
- |
|
| Horan Christopher |
Chief Tech Operations Officer |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
85,000 |
|
- |
|
| Krishnamohan Neha |
Chief Financial Officer |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
110,000 |
|
- |
|
| Bush Jennifer |
COO, CLO, Secy, Compliance Off |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
86,650 |
159,449 |
|
- |
|
| Raymon Heather |
SVP, Research and Development |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
33,350 |
43,350 |
|
- |
|
| Graef Thorsten |
Chief Medical Officer |
• – – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
80,000 |
|
- |
|
| Bush Jennifer |
COO, CLO, Secy, Compliance Off |
• – – |
2024-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
72,799 |
|
- |
|
| Krishnamohan Neha |
Chief Financial Officer |
• – – |
2024-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Graef Thorsten |
Chief Medical Officer |
• – – |
2024-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
|
- |
|
| Raymon Heather |
SVP, Research and Development |
• – – |
2024-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
|
- |
|
| Horan Christopher |
Chief Tech Operations Officer |
• – – |
2024-09-12 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
25,000 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2024-07-22 |
4 |
B |
$12.00 |
$99,999,996 |
I/I |
8,333,333 |
826,832 |
2.25 |
- |
|
| Shah Rajeev M. |
Director |
– • • |
2024-07-22 |
4 |
A |
$10.20 |
$4,709,207 |
I/I |
461,687 |
138,506 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2024-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,058,282 |
68,320 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2024-07-22 |
4 |
B |
$12.00 |
$9,999,996 |
I/I |
833,333 |
1,182,054 |
1.5 |
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2024-07-22 |
4 |
A |
$10.20 |
$4,709,207 |
I/I |
461,687 |
348,721 |
|
- |
|
| Schwab Andrew J. |
10% Owner |
– – • |
2024-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,058,284 |
1,058,284 |
|
- |
|
| Wellington Biomedical Innovation Master Investors |
|
– – • |
2024-07-22 |
4 |
A |
$10.20 |
$499,994 |
D/D |
49,019 |
194,108 |
|
- |
|
| Wellington Biomedical Innovation Master Investors |
|
– – • |
2024-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
145,089 |
145,089 |
|
- |
|
| Goodman Corey S |
|
• • • |
2024-07-22 |
4 |
B |
$12.00 |
$4,999,992 |
D/D |
416,666 |
1,936,637 |
0.01 |
- |
|
| Goodman Corey S |
|
• • • |
2024-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
461,687 |
1,519,971 |
|
- |
|
| Goodman Corey S |
|
• • • |
2024-07-22 |
4 |
A |
$0.00 |
$0 |
D/D |
1,058,284 |
1,058,284 |
|
- |
|
| Huh Yong-Jun |
|
– • – |
2024-07-22 |
4 |
B |
$12.00 |
$24,999,984 |
I/I |
2,083,332 |
1,260,512 |
0.01 |
- |
|
| Huh Yong-Jun |
|
– • – |
2024-07-22 |
4 |
A |
$10.20 |
$5,614,417 |
I/I |
550,433 |
843,846 |
|
- |
|
37 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
